Axonics bids for FDA approval of sacral neuromod device

Axonics bids for FDA approval of sacral neuromod device

Submitted by admin on December 4, 2018 - 9:46am
Source: 
Mass Device
News Tags: 
devices
Axonics
sacral neuromodulation
neuromodulation
urinary dysfunction
bowel dysfunction
Headline: 
Axonics bids for FDA approval of sacral neuromod device
snippet: 

Fresh from a $138 million initial public offering, Axonics Modulation Technologies(NSDQ:AXNX) said today that it re-filed yesterday for pre-market approval from the FDA for its r-SNM sacral neuromodulation treatment for urinary and bowel dysfunction.

Do Not Allow Advertisers to Use My Personal information